CWM
ESPR

CIBC World Markets’s Esperion Therapeutics ESPR Stock Holding History

CIBC World Markets’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$57.3K Buy
+15,477
New +$50K ﹤0.01% 1190
2025
Q2 		$24.2K Sell
24,604
-17,324
-41% -$17.3K ﹤0.01% 1524
2025
Q1 		$60.4K Buy
41,928
+24,245
+137% +$44.7K ﹤0.01% 1682
2024
Q4 		$38.9K Buy
+17,683
New +$41.3K ﹤0.01% 1277

Other funds holding ESPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC World Markets's ESPR Position: Q4 2025 in Review

CIBC World Markets opened a new position in Esperion Therapeutics (ESPR) in Q4 2025: 15,477 shares worth $57.3K. The stake represents ﹤0.01% of the portfolio and ranks #1190 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ESPR as recently as Q2 2025.

CIBC World Markets first reported a position in ESPR in Q4 2024 and has held it in 4 quarters since. The position peaked at $60.4K in Q1 2025. 200 funds tracked by Wall St. Rank hold ESPR as of Q4 2025.

  • CIBC World Markets held 15,477 shares of Esperion Therapeutics worth $57.3K as of Q4 2025.
  • Esperion Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Esperion Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1190 holding.
  • CIBC World Markets first reported a position in Esperion Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Esperion Therapeutics position peaked at $60.4K in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.